Benutzer: Gast  Login
Titel:

MALDI Mass Spectrometry Imaging-Prognostic Pathways and Metabolites for Renal Cell Carcinomas.

Dokumenttyp:
Journal Article
Autor(en):
Erlmeier, Franziska; Sun, Na; Shen, Jian; Feuchtinger, Annette; Buck, Achim; Prade, Verena M; Kunzke, Thomas; Schraml, Peter; Moch, Holger; Autenrieth, Michael; Weichert, Wilko; Hartmann, Arndt; Walch, Axel
Abstract:
High mass resolution matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) is a suitable method for biomarker detection for several tumor entities. Renal cell carcinoma (RCC) is the seventh most common cancer type and accounts for more than 80% of all renal tumors. Prognostic biomarkers for RCC are still missing. Therefore, we analyzed a large, multicenter cohort including the three most common RCC subtypes (clear cell RCC (ccRCC), papillary RCC (pRCC) and chromopho...     »
Zeitschriftentitel:
Cancers (Basel)
Jahr:
2022
Band / Volume:
14
Heft / Issue:
7
Volltext / DOI:
doi:10.3390/cancers14071763
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/35406537
TUM Einrichtung:
Institut für Allgemeine Pathologie und Pathologische Anatomie; Klinik und Poliklinik für Urologie
 BibTeX